Allogene Therapeutics, Inc. (ALLO)
NASDAQ: ALLO · Real-Time Price · USD
1.650
-0.020 (-1.20%)
At close: Sep 25, 2026, 4:00 PM EDT
1.657
+0.007 (0.42%)
After-hours: Sep 25, 2026, 7:48 PM EDT
Allogene Therapeutics Market Cap
Allogene Therapeutics has a market cap or net worth of $570.06 million as of September 25, 2026. Its market cap has increased by 108.88% in one year.
Market Cap
570.06M
Enterprise Value
316.46M
1-Year Change
108.88%
Ranking
Category
Stock Price
$1.65
ChartMarket Cap Chart
Since October 11, 2018, Allogene Therapeutics's market cap has decreased from $2.88B to $570.06M, a decrease of -80.21%. That is a compound annual growth rate of -18.41%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 570.06M | 85.16% |
| Dec 31, 2025 | 307.88M | -31.06% |
| Dec 31, 2024 | 446.60M | -17.32% |
| Dec 29, 2023 | 540.17M | -40.45% |
| Dec 30, 2022 | 907.08M | -57.34% |
| Dec 31, 2021 | 2.13B | -39.95% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 11, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| CorMedix | 630.57M |
| Phathom Pharmaceuticals | 619.55M |
| Prime Medicine | 615.03M |
| Valneva SE | 614.36M |
| Bright Minds Biosciences | 607.73M |
| Ginkgo Bioworks Holdings | 606.06M |
| MapLight Therapeutics | 603.55M |
| Eupraxia Pharmaceuticals | 565.96M |